Trials / Unknown
UnknownNCT01420510
Saginil in vs. Placebo for Gynecologic Oncology Patients Affected by Vaginitis
Saginil in Vaginal Cannulas vs. Placebo for the Prevention of Vaginitis in Gynecologic Oncologic Patients Receiving Chemotherapy: a Randomized Controlled Trial.
- Status
- Unknown
- Phase
- Phase 2 / Phase 3
- Study type
- Interventional
- Enrollment
- 60 (estimated)
- Sponsor
- Università degli Studi dell'Insubria · Academic / Other
- Sex
- Female
- Age
- —
- Healthy volunteers
- Not accepted
Summary
We hypothesise that the use of Adelmidrol (Saginil in vaginal cannulas) can reduce the incidence and magnitude of vaginitis in patients affected by gynecologic malignancies.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Adelmidrol vaginal gel | Application of a Adelmidrol vaginal gel |
| DRUG | Placebo vaginal gel | Application of a placebo vaginal gel |
Timeline
- Start date
- 2011-09-01
- Primary completion
- 2014-11-01
- Completion
- 2014-12-01
- First posted
- 2011-08-19
- Last updated
- 2013-06-21
Locations
1 site across 1 country: Italy
Source: ClinicalTrials.gov record NCT01420510. Inclusion in this directory is not an endorsement.